Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Cantor Fitzgerald
Daiichi Sankyo
AstraZeneca
Citi
Mallinckrodt
Novartis
Merck
Healthtrust
Colorcon

Generated: February 19, 2018

DrugPatentWatch Database Preview

DESOXYN Drug Profile

« Back to Dashboard

When do Desoxyn patents expire, and when can generic versions of Desoxyn launch?

Desoxyn is a drug marketed by Recordati Rare and is included in one NDA.

The generic ingredient in DESOXYN is methamphetamine hydrochloride. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.

US Patents and Regulatory Information for DESOXYN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET;ORAL 005378-002 Approved Prior to Jan 1, 1982 AA RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recordati Rare DESOXYN methamphetamine hydrochloride TABLET, EXTENDED RELEASE;ORAL 005378-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
Express Scripts
Dow
Johnson and Johnson
QuintilesIMS
Merck
Moodys
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot